eprintid: 10040273
rev_number: 24
eprint_status: archive
userid: 608
dir: disk0/10/04/02/73
datestamp: 2017-12-19 11:22:28
lastmod: 2020-06-09 09:54:27
status_changed: 2017-12-19 11:22:28
type: article
metadata_visibility: show
creators_name: Ryerson, CJ
creators_name: Denton, CP
title: The Fine Line Between Success and Failure in Scleroderma Lung Fibrosis Trials
ispublished: pub
subjects: RFH
divisions: UCL
divisions: A01
divisions: B02
divisions: C10
divisions: D17
divisions: G90
keywords: Forced vital capacity, Interstitial lung disease, Minimum clinically important difference, Outcomes, Systemic sclerosis
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
date: 2017
date_type: published
official_url: https://doi.org/10.1164/rccm.201711-2268ED
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
article_type_text: Journal Article
verified: verified_manual
elements_id: 1513564
doi: 10.1164/rccm.201711-2268ED
lyricists_name: Denton, Christopher
lyricists_id: CPDEN87
actors_name: Denton, Christopher
actors_id: CPDEN87
actors_role: owner
full_text_status: public
publication: American Journal of Respiratory and Critical Care Medicine
volume: 197
number: 5
pagerange: 553-554
event_location: United States
issn: 1535-4970
citation:        Ryerson, CJ;    Denton, CP;      (2017)    The Fine Line Between Success and Failure in Scleroderma Lung Fibrosis Trials.                   American Journal of Respiratory and Critical Care Medicine , 197  (5)   pp. 553-554.    10.1164/rccm.201711-2268ED <https://doi.org/10.1164/rccm.201711-2268ED>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10040273/1/Ryerson%20and%20Denton%202017%20editorial%20reprint%20AJRCCM.pdf